Literature DB >> 10702784

Pathology and clinical correlates in oral candidiasis and its variants: a review.

P A Reichart1, L P Samaranayake, H P Philipsen.   

Abstract

Although Candida albicans is well recognised as the major agent of oral candidiasis, it is not clear why several variants such as pseudomembranous (PC), erythematous (EC) and hyperplastic candidiasis (HC) manifest in different individuals, sometimes singly and on other occasions, in combination. The present review focuses on recent histopathologic and immunocytochemical studies as well as the pathogenic attributes of the yeast, in an attempt to address the following queries. (1) Do histopathologic studies of the different variants of candidiasis in immunocompetent and immunocompromised individuals help explain these varying manifestations? (2) Under what circumstances does oral candidiasis manifest as a pseudomembranous rather than an erythematous lesion or vice versa? (3) Are there differences in immunoreactivity in closely adjacent mucosae so that the variable presentation of such lesions reflect differences in the local mucosal immune system? Recent studies of PC, EC and HC offer some insights into the pathogenic mechanisms involved. Histopathologic and immunohistochemical finding in cases of PC and EC in HIV-infected patients and controls appear to be comparable, with a marked reduction or even an absence of CD4+ cells. The latter phenomenon is marked in PC compared with the EC, and explicable in terms of a breakdown of the local immune response in the former, and a hypersensitivity reaction against Candida antigens in the latter. Hyperplastic candidiasis on the other hand could be considered a superficial cellular reaction against the pathogen, which cannot entirely be eradicated by the systemic or local host immune response. The virulent attributes of the fungus, such as the production of extracellular proteinases, do significantly differ within and between species and thereby play a contributory role in the genesis of the clinical variants. Although the available data do give a tantalising glimpse of the contributory mechanisms for the aetiopathology of PC, EC and HC, further research is warranted to elucidate response of the host to this ubiquitous fungal pathogen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702784     DOI: 10.1111/j.1601-0825.2000.tb00106.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  20 in total

1.  CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.

Authors:  K Quimby; E A Lilly; M Zacharek; K McNulty; J E Leigh; J E Vazquez; P L Fidel
Journal:  Oral Dis       Date:  2011-09-30       Impact factor: 3.511

2.  Rapid identification of Candida species in oral rinse solutions by PCR.

Authors:  Giorgio Liguori; Angela Lucariello; Giuseppe Colella; Antonio De Luca; Paolo Marinelli
Journal:  J Clin Pathol       Date:  2007-09       Impact factor: 3.411

3.  An In-vitro Evaluation of Retention, Colonization and Penetration of Commonly Used Denture Lining Materials By Candida albicans.

Authors:  Sushma Krishnamurthy; Rajendra B Hallikerimath
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 4.  Experimental oral candidiasis in animal models.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  Characterization of CD8+ T cells and microenvironment in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis.

Authors:  Kelly M McNulty; Jananya Plianrungsi; Janet E Leigh; Donald Mercante; Paul L Fidel
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry.

Authors:  Tomoko Komatsu; Erdjan Salih; Eva J Helmerhorst; Gwynneth D Offner; Frank G Oppenheim
Journal:  J Proteome Res       Date:  2010-12-06       Impact factor: 4.466

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Fast-acting clotrimazole composited PVP/HPβCD nanofibers for oral candidiasis application.

Authors:  Prasopchai Tonglairoum; Tanasait Ngawhirunpat; Theerasak Rojanarata; Ruchadaporn Kaomongkolgit; Praneet Opanasopit
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

9.  Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.

Authors:  Tammy A Myers; Janet E Leigh; Alfredo R Arribas; Shannon Hager; Rebecca Clark; Elizabeth Lilly; Paul L Fidel
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.

Authors:  Miriam Marquis; Daniel Lewandowski; Véronique Dugas; Francine Aumont; Serge Sénéchal; Paul Jolicoeur; Zaher Hanna; Louis de Repentigny
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.